FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

NH Consensus Forecast

No. of reports in last year
4
No. of analysts
3
Average Consensus Forecast
560.5
Consensus Potential
8.12%

NH Price Target Potential

BrokerageTargetPotential
Geojit Financial Services5618.24%
HDFC Securities57510.47%
ICICIdirect.com5455.54%

NH Ratings

Long term NH rating by FrontPage users
5/5 (2 Ratings)

4 NH share price target reports by brokerages below. See what is analyst's view on NH share price forecast, rating, estimates, valuation and prediction behind the target. You may use these research report forecasts for long-term to medium term for your investment or trades in 2020.
  1. Home
  2. NH Forum
  3. NH Price Target

NH Share Price Target

NH Share Price Target - Broker Reports - 2021

8-Jun-21
Price @ Call: 482
Target: 561
ACCUMULATE
10-Aug-21
Price @ Call: 514.85
Target: 575
ADD
8-Jun-21
Price @ Call: 482.4
Target: 561
ACCUMULATE
22-Feb-21
Price @ Call: 462.2
Target: 545
BUY

NH Share Price Target - Broker Reports - 2020

4-Feb-20
Price @ Call: 367.3
Target: 430
BUY
The quarter was soft due to seasonality impact and shutdown of Whitefield facility (Bangalore). New hospitals (SRCC, Gurugram, Dharamshila) continue to see reduction in losses as the ramp-up in these assets. The management is currently focusing on improving efficiency and capacity of existing hospitals and less focus on greenfield or M&A front, which should improve the return ratios gradually. The improvement and sustainability of these vital prints hold key as the focus now shifts to improvement in operating leverage which is visible in 9M performance. The improvement in numbers over the last few quarters is also on the back of judicious case mix identification (more focus on oncology, transplants as well as non-invasive procedures). We continue to believe in the long term prospects of the company on the back of asset-right model and affordability philosophy. We arrive at an SOTP target price of | 430 by valuing the matured hospitals and Cayman Islands at 10x of FY22E EV/EBITDA, new hospitals at 1.5x FY22E EV/sales and other business at 1x FY22E EV/sales.
... Read more

NH Share Price Target - Broker Reports - 2019

10-Dec-19
Price @ Call: 311.81
Target: 360
BUY
A persistent improvement in occupancy rate across all segments coupled with substantial seasonality impact propelled both revenue growth, margins in H1. The new hospitals (SRCC, Gurugram, Dharamshila) continue to see a reduction in losses as the ramp-up in these assets is slowly but surely improving. The management reiterated a significant moderation in capex. On the M&A front, this should improve return ratios gradually. The improvement, sustainability of these vital prints hold key as the focus now shifts to improvement in operating leverage. This was clearly visible in H1 performance. The improvement in numbers over the last few quarters is also on the back of a judicious case mix identification (more focus on transplants as well as non-invasive procedures). We continue to believe in the long term prospects of the company on the back of asset-right model and affordability philosophy. We arrive at an SOTP target price of | 360 by valuing the matured hospitals and Cayman Islands at 8x of FY22E EV/EBITDA, new hospitals at 1.5x FY22E EV/sales and other business at 1x FY22E EV/sales.
... Read more
19-Jun-19
Price @ Call: 227.61
Target: 282
BUY
Recommend Buy with a TP of INR 282
NARH reported strong operating performance in FY19, which is likely to sustain. Given its low-cost model and scale-up in new hospitals, it is well positioned to benefit from growing demand. In the near term, losses from newer hospitals would hurt profitability. At the CMP, the stock trades at an attractive valuation of 12x FY21E EV/EBITDA. We reiterate Buy with a TP of INR 282 on 15x FY21E EV/EBITDA.
... Read more
28-May-19
Price @ Call: 226.7
Target: 260
HOLD
Overall margins have improved mainly due to strong margins at Cayman and firm margins at the matured hospitals. The new hospitals, SRCC, Gurugram and Dharamshila continue to remain in investment mode for at least next one and a half to three years as the ramp-up in these assets is happening rather slowly. However, the management has reiterated a significant moderation in capex and M&A activities, which should improve the return ratios gradually. That said, the improvement and sustainability of margin holds key as any further slowdown in margins could worsen the situation in the near term. We continue to believe in the long term prospects of the company on the back of the asset-right model and affordability philosophy. We arrive at an SOTP target price of Rs 260 by valuing the matured hospitals and Cayman Islands at 8x of FY21E EV/EBITDA and other hospitals & other businesses at 1x FY21E EV/sales.
... Read more
6-Feb-19
Price @ Call: 194.1
Target: 250
BUY

NH Share Price Target - Broker Reports - 2017

26-Dec-17
Price @ Call: 296
Target: 360
BUY
11-Dec-17
Price @ Call: 288
Target: 340
BUY
14-Nov-17
Price @ Call: 293
Target: 348
BUY
10-Aug-17
Price @ Call: 302
Target: 363
BUY
13-Jun-17
Price @ Call: 338.2
Target: 422
BUY
8-Feb-17
Price @ Call: 328
Target: 340
HOLD

NH Share Price Target - Broker Reports - 2016

27-Sep-16
Price @ Call: 325.55
Target: 400
BUY
Join FrontPage
Hero Img
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • NH Share Price Target Today- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 3545.77
    Upside Target 2536.83
    Upside Target 1531.02
    Pivot522.08
    Downside Target 1516.27
    Downside Target 2507.33
    Downside Target 3501.52
  • NH Share Price Target weekly- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 3550.53
    Upside Target 2534.27
    Upside Target 1524.53
    Pivot508.27
    Downside Target 1498.53
    Downside Target 2482.27
    Downside Target 3472.53
  • NH Share Price Target monthly- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 3607.47
    Upside Target 2584.73
    Upside Target 1543.52
    Pivot520.78
    Downside Target 1479.57
    Downside Target 2456.83
    Downside Target 3415.62
  • NH Share Price Target today- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 3536.83
    Upside Target 2531.2
    Upside Target 1527.72
    Pivot522.08
    Downside Target 1516.45
    Downside Target 2512.97
    Downside Target 3507.33
  • NH Share Price Target weekly- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 3534.27
    Upside Target 2524.33
    Upside Target 1518.2
    Pivot508.27
    Downside Target 1498.33
    Downside Target 2492.2
    Downside Target 3482.27
  • NH Share Price Target monthly- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 3584.73
    Upside Target 2560.3
    Upside Target 1545.21
    Pivot520.78
    Downside Target 1496.35
    Downside Target 2481.26
    Downside Target 3456.83
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.
PrivacyTerms
FrontPage © 2020